Home » Topics » BioWorld

BioWorld
RSS

INJUNCTION SOUGHT ON SALES OF FACTOR VIII:C

Sep. 13, 1991

INNOVET DELIVERY FOR CYANAMID DRUG

Sep. 13, 1991

SYTRO LICENSES VACCINE IN EUROPE

Sep. 13, 1991

SEARLE LICENSES ALZA DRUG DELIVERY SYSTEM

Sep. 12, 1991

IMMUNE RESPONSE ENROLLS PATIENTS FOR TRIALS

Sep. 12, 1991

ANALYST BEGINS COVERAGE OF ECOGEN

Sep. 12, 1991

ONCOR LICENSES LEUKEMIA PROBES

Sep. 12, 1991

CAL BIO SBIR FOR HEART FAILURE DRUGS

Sep. 12, 1991

ANIMAL TESTING BILL VETOED IN CALIFORNIA

Sep. 12, 1991

SANDOZ GETS EUROPEAN PATENT FOR GM-CSF

Sep. 12, 1991

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...